Are Your Trial Payments Creating Hidden Compliance Risks?

Small, well-intentioned decisions at the site level can quietly introduce significant compliance risk into clinical trials. When payment workflows are fragmented or handled ad hoc, the lines between site payments, patient reimbursements, and stipends blur — creating exposure across regulatory, financial, and ethical dimensions.

Each payment type carries distinct requirements: reimbursements must be documented and non-taxable, stipends must be tracked as taxable income, and site payments must align with contractual obligations. Without clear separation and consistent oversight, even minor inconsistencies can trigger audit issues or raise concerns about undue influence in patient participation.

A centralized, transparent approach replaces uncertainty with control — enforcing compliance, improving documentation, and ensuring fair, consistent practices across all sites. Strengthening these financial workflows protects trial integrity while easing administrative burden.